/filters:format(webp)/production/3760438/large-1618944708.png?1618944708)
NotHopeJustFacts
$DMRA can someone remind me why did i buy this trash (i bought it under Galecto) cause on my side they look as heavy bags... LOL
DMRA Damora Therapeutics Inc.
$21.60
$0.45
(2.04%)
Closed $21.60
$0.00
(0.00%)
After Hours
Reported EarningsNov 4
Mkt Cap$1.34B
Vol475,267.00
About DMRA
Damora Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Waltham, MA.
Fundamentals
45
Neutral Sentiment
How do you feel about DMRA?
Advertisement|Remove ads.
Latest DMRA News
ViewWhy This Fund Made a $66 Million Bet on Damora Therapeutics Amid a 700% Surge
Nasdaq News: Markets
Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Shares Gap Down - Here's Why
MarketBeat
Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Sees Large Increase in Short Interest
MarketBeat
StocktwitsPolls21
72StocktwitsPolls126
208StocktwitsPolls137
204Advertisement|Remove ads.